Cargando…
Molecular Targets and Signaling Pathways in Cholangiocarcinoma: A Systematic Review
BACKGROUND: Cholangiocarcinoma (CCA) is the second most frequent hepatobiliary cancer after hepatocellular carcinoma with a poor prognosis and limited treatment options. This study aimed to review existing knowledge on the genetic basis of CCA, molecular targets/signaling pathways involved in the pa...
Autores principales: | Idris, Rehab, Chaijaroenkul, Wanna, Na-Bangchang, Kesara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334076/ https://www.ncbi.nlm.nih.gov/pubmed/36974526 http://dx.doi.org/10.31557/APJCP.2023.24.3.741 |
Ejemplares similares
-
Notch signaling in the pathogenesis, progression and identification of potential targets for cholangiocarcinoma (Review)
por: Vanaroj, Peeranate, et al.
Publicado: (2022) -
Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway
por: Vanaroj, Peeranate, et al.
Publicado: (2023) -
Proteomics Analysis for Identification of Potential Cell Signaling Pathways and Protein Targets of Actions of Atractylodin and β-Eudesmol Against Cholangiocarcinoma
por: Kotawong, Kanawut, et al.
Publicado: (2020) -
Screening of Molecular Targets of Action of Atractylodin in Cholangiocarcinoma by Applying Proteomic and Metabolomic Approaches
por: Kotawong, Kanawut, et al.
Publicado: (2019) -
The Proteomics and Metabolomics Analysis for Screening the Molecular Targets of Action of β-Eudesmol in Cholangiocarcinoma
por: Kotawong, Kanawut, et al.
Publicado: (2021)